Heilongjiang ZBD Pharmaceutical Co Ltd Tangible Net Worth Ratio
Heilongjiang ZBD Pharmaceutical Co Ltd tangible net worth ratio. Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has a Tangible Net Worth Ratio of 79.9% as of March 2026. This metric is calculated by deducting intangible assets (CN¥1.23 Billion) from net assets (CN¥6.14 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check asset allocation strategy of Heilongjiang ZBD Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Heilongjiang ZBD Pharmaceutical Co Ltd (2011–2025)
Tangible net worth ratio of Heilongjiang ZBD Pharmaceutical Co Ltd from 2011 to 2025. This chart shows how Heilongjiang ZBD Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 15 annual periods from 2011 to 2025. As of March 2026, the ratio stands at 79.9%, reflecting net assets of CN¥6.14 Billion with intangible assets of CN¥1.23 Billion CNY. See 603567 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Heilongjiang ZBD Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (2011–2025)
Heilongjiang ZBD Pharmaceutical Co Ltd tangible net worth ratio by year from 2011 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Heilongjiang ZBD Pharmaceutical Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Heilongjiang ZBD Pharmaceutical Co Ltd stock valuation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 80.2% | CN¥6.28 Billion | CN¥1.24 Billion | CN¥10.63 Billion | ▼ -5.5 pp |
| 2024 | 85.7% | CN¥8.29 Billion | CN¥1.18 Billion | CN¥12.71 Billion | ▼ -1.9 pp |
| 2023 | 87.6% | CN¥8.04 Billion | CN¥994.34 Million | CN¥12.47 Billion | ▲ +1.2 pp |
| 2022 | 86.5% | CN¥7.11 Billion | CN¥962.78 Million | CN¥11.68 Billion | ▼ -8.6 pp |
| 2021 | 95.1% | CN¥7.05 Billion | CN¥348.70 Million | CN¥11.51 Billion | ▼ -0.3 pp |
| 2020 | 95.4% | CN¥5.50 Billion | CN¥254.31 Million | CN¥10.23 Billion | ▲ +0.1 pp |
| 2019 | 95.3% | CN¥5.25 Billion | CN¥246.44 Million | CN¥9.02 Billion | ▲ +0.0 pp |
| 2018 | 95.3% | CN¥4.98 Billion | CN¥233.97 Million | CN¥8.18 Billion | ▲ +0.2 pp |
| 2017 | 95.1% | CN¥4.68 Billion | CN¥229.57 Million | CN¥6.89 Billion | ▲ +0.1 pp |
| 2016 | 95.0% | CN¥4.31 Billion | CN¥217.40 Million | CN¥6.42 Billion | ▼ -0.7 pp |
| 2015 | 95.6% | CN¥3.98 Billion | CN¥174.43 Million | CN¥5.95 Billion | ▲ +4.1 pp |
| 2014 | 91.5% | CN¥2.17 Billion | CN¥184.37 Million | CN¥3.60 Billion | ▲ +2.6 pp |
| 2013 | 88.9% | CN¥1.75 Billion | CN¥193.61 Million | CN¥3.25 Billion | ▲ +0.9 pp |
| 2012 | 88.0% | CN¥1.32 Billion | CN¥158.41 Million | CN¥2.13 Billion | ▼ -5.1 pp |
| 2011 | 93.1% | CN¥923.09 Million | CN¥63.84 Million | CN¥1.44 Billion | — |